Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Type 1 Diabetes Delayed in Mice by Stem Cell-Derived Vesicles That Calm Immune Response

Extracellular vesicles produced by certain types of pluripotent stem cells (PSC) were found to help reduce immune attacks on insulin-producing cells in the pancreas and delay the onset of diabetes in a mouse model. The post Type 1 Diabetes Delayed in Mice by Stem Cell-Derived Vesicles That Calm Immune Response appeared first on GEN - Genetic Engineering and Biotechnology News .

Type 1 diabetes is an autoimmune condition in which the immune system mistakenly attacks insulin-producing cells in the pancreas, preventing proper blood sugar regulation. Current treatment involves insulin therapy, but it does not address the underlying immune attack. Researchers at UCLA have discovered that extracellular vesicles (EVs) derived from pluripotent stem cells (PSCs) may help protect these insulin-producing cells and delay the onset of diabetes in mice.

PSCs are cells that can differentiate into any cell type, resembling early embryonic cells. These vesicles naturally release communication molecules between cells. The UCLA study compared EVs from embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) to those from mesenchymal stem cells (MSCs), which have been studied for their anti-inflammatory properties.

The team found that PSC-derived EVs exhibited stronger anti-inflammatory effects than MSC-derived EVs and promoted the formation of regulatory T cells (Tregs), which prevent the immune system from attacking the body's own tissues.

The researchers injected mice with immune cells that target insulin-producing pancreatic cells and then treated the animals with PSC-derived EVs. To ensure the EVs had a sustained effect, they created an injectable hydrogel that slowly releases the vesicles over several days. The treatment significantly delayed the onset of diabetes in the mice, with 55% remaining diabetes-free after 90 days.

This hydrogel method could potentially deliver the immune-regulating vesicles systemically, protecting insulin-producing cells throughout the body. The discovery of these unique vesicles with their distinct molecular signatures provides a promising strategy for preserving insulin-producing cells in individuals with type 1 diabetes.

Written by urgent.news from GEN Biotechnology's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

This story

This is one outlet's version. Read the fullest account.

Every outlet that reported this, and when →

Read the original at genengnews.com →

More in Health & Medicine

More from Thursday 19 November →